Editor's key points † Inhalation general anaesthesia can be maintained during cardiopulmonary bypass with sevoflurane administered via fresh gas delivery to the membrane oxygenator. † Sevoflurane uptake can be quantified by direct measurement of arterial plasma concentration. † The uptake of sevoflurane via the oxygenator is related to oxygenator fresh gas flow, and can be affected by the degree of hypothermia and haemodilution. † Measured plasma sevoflurane concentrations are unrelated to the concentration of sevoflurane measured in the oxygenator exhaust gas.
When volatile anaesthetics are administered via the anaesthetic circuit and ventilator, delivery is controlled by monitoring the end-tidal anaesthetic concentration. 7 -9 However, the dosage of volatile anaesthetics in the oxygenator fresh gas supply is often chosen empirically because pulmonary perfusion and ventilation are partially reduced or completely stopped during CPB. The factors that influence the sevoflurane uptake across the oxygenator membrane remain difficult to predict and the solubility of volatile anaesthetics in blood depends on blood temperature and the degree of crystalloid haemodilution. 10 -12 Although sevoflurane has often been used in studies on the cardioprotective effects of volatile anaesthetics, thus far, there have been no in vivo studies that have analysed sevoflurane plasma concentration (SPC) during the course of CPB in a routine clinical setting.
intraoperative awareness. Although there is no point-of-care monitoring for SPC, hypnotic depth can be monitored either by extrapolating from measured end-tidal anaesthetic gas concentrations or by using electroencephalographic-based monitoring systems, such as the bispectral index (BIS, BIS TM monitor; Covidien, Boulder, CO, USA), to prevent awareness. 14 -16 The present study was designed to answer three questions: first of all, are there significant changes in SPC and BIS values during on-pump cardiac surgery? And if so, what clinical factors influence SPC during CPB? Thirdly, is there a reasonable correlation between SPC and the sevoflurane concentration in the exhaust gas from the oxygenator? The following null hypothesis was tested: if a constant concentration of sevoflurane was administered before and during CPB, there are no changes in SPC and BIS values and the SPC is independent from patient temperature, haemodilution, the oxygenator fresh gas flow, and the sevoflurane concentration in the exhaust gas from the oxygenator.
Methods
This investigation was designed as a prospective, clinical, observational study. The study protocol was approved by the regional review board of the Medical Council of Hamburg, Germany (reference number PV3623).
Patient population
Adult patients undergoing elective cardiac surgery requiring CPB were recruited. Inclusion criteria were elective cardiac surgery, written informed consent, and ASA status III-IV. Patients with ASA classification ,III and .IV, a contraindication for the application of volatile anaesthetics, an active infection with temperature .38.08C, or any history of a neurological disease were excluded from this study.
Anaesthetic management
The techniques used for anaesthesia, surgery, and CPB followed routine institutional practice. Patients received 7.5 mg midazolam for premedication 60 min before induction of anaesthesia. Routine monitoring included five-lead electrocardiogram and pulse oximetry. 
CPB circuit
The CPB circuit contained a roller pump (Stockert S5; Sorin Group, Munich, Germany) and a hollow fibre microporous polypropylene (PPL) membrane oxygenator with a hardshell venous reservoir (Compactflo Evolution TM ; Sorin Group). The bypass circuit was primed using 1300 ml Ringer's solution, 100 ml mannitol (20%), 60 ml sodium hydrogen carbonate (8.4%), and 5000 units of heparin. After aortic crossclamping, cold crystalloid Bretschneider cardioplegic solution (Custodiol TM ; Dr Franz Koehler Chemie, Bensheim, Germany) was administered and patients were cooled to 30-348C based on the cardiac surgeon's preference. a-Stat blood gas management was used to control acid -base balance in all patients. The target blood flow during CPB was 2.4 litre min 21 m 2 and was increased up to 3.2 litre min 21 m 2 in order to maintain oxygen saturation in the venous outflow line above 75%. The activated clotting time was 480 s (10%) during CPB. The rate of fresh gas flow in the oxygenator gas supply was adapted by the perfusionist to maintain the arterial carbon dioxide partial pressure between 5.3 and 6.0 kPa. There was no institutional protocol of a fixed gas:blood flow ratio. The oxygen concentration in the gas mix delivered to the oxygenator was 30-80% depending on arterial oxygen partial pressure with a target oxygen partial pressure of 25.0 kPa measured in the oxygenated arterial inflow. From the start of CPB, a constant concentration of 1.8 vol% sevoflurane was administered via the oxygenator fresh gas supply using a common anaesthetic vaporizer (Draeger Vapor TM Version 19.3 and Version 2000; Draeger). The concentration of sevoflurane was measured in the gas supply line of the oxygenator and the scavenger line of the oxygenator exhaust gas 30 cm behind the oxygenator hardshell using a side-stream infrared anaesthetic gas analyzer (Vamos TM ; Draeger) at a sample flow rate of 200 ml min 21 .
The anaesthetic gas scavenging system (AGSS TM ; Draeger)
connected to the gas exhaust of the oxygenator had a suction capacity of 50 litre min 21 and a limit to the suction pressure set to a maximum of 0.01 mbar. After successful weaning from CPB, sevoflurane was again administered at an inspiratory concentration of 1.8 vol% via the respirator.
Study protocol
Blood samples for analysis of haematocrit, plasma albumin concentration, and SPC were obtained from the radial artery catheter at predefined time intervals. The points at which measurements were taken are shown in Table 1 . BIS values were recorded at baseline before induction of anaesthesia and at 1 min intervals during the entire surgical procedure. Evaluation of intraoperative anaesthesia awareness was performed using the Brice questionnaire. 17 Patients were interviewed between 24 and 72 h after tracheal extubation.
Gas chromatographic analysis of SPC
Arterial blood samples for gas chromatography were collected in 2 ml syringes (PICO50 TM ; Radiometer, Copenhagen, Denmark) containing 80 units electrolyte-balanced heparin. All tightly capped syringes were stored at +88C immediately after blood sampling. Measurements of SPC were performed within 8 h using a gas chromatography-flame ionizations detector (Clarus TM 500; PerkinElmer, Shelton, UK) with an automatic sampler for headspace analysis (TurboMatrix TM ; HS 40, PerkinElmer) and a 75 m×0.53 mm ID capillary column (Elite 624; PerkinElmer). A sample of 2 ml heparinized whole blood was centrifuged for 5 min and 500 ml of plasma supernatant was transferred into the 20 ml headspace vials. An aliquot of 50 ml halothane (EurimPharm, Saaldorf-Surheim, Germany) in acetone (Merck, Darmstadt, Germany) at a concentration of 1 mg ml 21 was added as an internal standard. Headspace vials were closed immediately, equilibrated, and pressurized. An aliquot was then withdrawn from the closed vial and transferred directly to the gas chromatographic system via a heated fused-silica transfer line. The sample was heated to 608C for 10 min before injection into the gas chromatograph at 1508C. The temperature of the detector was 2008C. The retention times of the added substances were 4.6 min for sevoflurane, 5.0 min for acetone, and 5.8 min for halothane. The quantification of SPC was achieved by preparing a linear calibration curve of exact standard solutions of the internal standard halothane and of sevoflurane (European Pharmacopoeia Reference, Dorset, UK) in acetone for each patient. The standard curves of the peak-area ratio (sevoflurane/internal standard halothane) vs analyte concentration were linear (coefficient of correlation r 2 .0.99)
for the range of the prepared solutions of 0, 20, 40, 60, 80, and 100 mg ml 21 sevoflurane. The limit of determination was 1.3 mg ml 21 with a limit of detection of 0.38 mg ml
21
sevoflurane. The inter-day coefficient of variations for quality-control samples containing 2 mg ml 21 sevoflurane was 6.33% (bias 8.1%) and 5.4% (bias 3.3%) for qualitycontrol samples containing 8 mg ml 21 sevoflurane.
Statistical analysis
Data are expressed as the mean with 95% confidence intervals (CIs) or as the mean [standard deviation (SD)] for population descriptions in Tables 2 and 3 . Before analysis, data distribution was checked for normality graphically and by using the Kolmogorov-Smirnov test. The progression of sevoflurane concentration and BIS over time was evaluated using analysis of variance models. Changes in the time course of the parameters were studied by fitting linear mixed random intercept models to the data, allowing for first-order autocorrelations and/or homoscedasticity between measurement times. The chosen models take into account that repeated measurements were performed within the same person. For these models, we calculated pairwise P-values for group differences at time T1 (sevoflurane administered through the anaesthesia ventilator) and T4 (17 min after the start of CPB). Measurement T4 was chosen for comparison with other measurements because at that time, we expected complete mixing of patient's blood volume and the priming volume of the CPB circuit and the implementation of hypothermia. A linear mixed effects model was used to estimate the influences of the variables patient temperature, haematocrit, and rate of the oxygenator fresh gas supply on the SPC. The Pearson correlation was used to measure the association between sevoflurane concentration in the gas outlet port of the oxygenator and the SPC. Two-tailed P-values below 0.05 were considered significant, without correction for multiple testing. Statistical analysis was performed using the SPSS statistical software package 19.0 (IBM SPSS Statistics Inc., Chicago, IL, USA) and the R statistical environment, version 2.14.1 (R Foundation for Statistical Computing, GNU, Boston, MA, USA).
Results
Thirty patients who were undergoing elective cardiac surgery were included in this prospective observational study. Data were collected between May 11, 2011, and July 20, 2011 at a university medical centre. All included patients completed the study protocol. One patient had to be excluded from data analysis due to implausibly high SPC values because a measurement artifact was suspected. Patient characteristics of the study population are provided in Table 2 .
The duration of CPB ranged from 58 to 263 min. Blood samples were collected from all 29 patients up to measurement T6 (47 min after the start of CPB). After this time point, the number of samples obtained declined due to the differences in the length of CPB (Table 1 ). Blood samples were obtained from all 29 patients at TX-1 before the initiation of weaning from CPB and at TX (5 min after the end of CPB) regardless of CPB duration ( (15/227) of sevoflurane in the oxygenator exhaust gas data were missing. All other data were collected successfully according to the study protocol (Table 3) . The results of the SPC analysis and the BIS values during the course of the observation period are illustrated in Figure 1 . SPC values over time showed a significant decrease directly after the onset of CPB (Fig. 1, Table 3 ). The SPC remained significantly lower in all measurements during and after 80   Measurements   A   B   T0  T1 T2 T3 T4  T5  T6  T7  T8  T9  T10  TX- T0  T1 T2 T3 T4  T5  T6  T7  T8  T9  T10  TX- CPB when compared with measurement T1, which was taken before the start of CPB (Table 3) . At 5 min after initiation of CPB, the SPC showed an increase to a stable plateau with no further significant changes in SPC until T8 (Table 3) . When compared with measurement T4, which was used as representative of this new stable plateau after equilibration, again a significant decline of the SPC from this plateau was found before weaning from CPB ( Fig. 1 , Table 3 ). The lowest SPC during CPB was 71.8% (39.4 mg ml 21 ) of the SPC at T1 (54.9 mg ml 21 ) and was observed after rewarming, before
weaning from CPB at TX-1 (Table 3) . After successful weaning from CPB, when sevoflurane was again administered via the ventilator, the SPC remained significantly lower compared with the stable administration of sevoflurane via the respirator before CPB at T1 and via the oxygenator at T4 (Fig. 1, Table 3 ). BIS values remained unchanged during the first 2 h of sevoflurane application via the oxygenator when compared with the T1 value when sevoflurane was administered via the ventilator and compared with the T4 value when sevoflurane was administered via the oxygenator and mild or moderate hypothermia were present and equilibration was accomplished (Table 3) . However, there was a significant increase in BIS values before weaning from CPB. BIS values were higher at T10 and TX-1 immediately before weaning from CPB compared with the T1 value when sevoflurane was administered via the ventilator before CPB and compared with T4 when sevoflurane was administered via the oxygenator (Table 3) . After weaning from CPB, BIS values exceeded values recorded before and during CPB ( Table 3) . Regardless of the statistically significant changes in BIS values, they never exceeded a value of 55 over the whole period. Figure 1 and Table 3 show the SPC data and the recorded BIS values during the entire observation period. No evidence of intraoperative awareness was detected.
The influence of changes in patient temperature, haematocrit, and oxygenator fresh gas flow on the SPC over the study period is presented in Figure 2 . In our study group, multivariate regression analysis revealed that a decrease in patient temperature of 18C caused an increase of 1.9 mg There was no correlation between the SPC and the concentration of sevoflurane in the oxygenator exhaust gas (Pearson r 20.04, P¼0.53; Fig. 3 ). In addition, we found only limited correlation between BIS values and the concentration of sevoflurane in the oxygenator exhaust gas [Pearson r 20.13, 95% CI: (20.01 to 0.06), P¼0.071].
Discussion
For the first time in a routine clinical setting, using sevoflurane application via an oxygenator membrane, the results of this study show an initial decrease in SPC after the initiation concentration measured in blood samples by gas chromatography and the concentration of sevoflurane in the oxygenator exhaust gas measured using a side-stream infrared anesthetic gas analyser in the study population. r ¼ Pearson coefficient for the correlation between SPC and the concentration of sevoflurane in the oxygenator exhaust gas.
of CPB and a second decrease in SPC that occurred in parallel with rewarming the patient before weaning from CPB. The study identified that hypothermia increased, haemodilution decreased, and an increase in the oxygenator fresh gas supply flow increased SPC during on-pump cardiac surgery. The uptake of sevoflurane across the PPL membrane of the oxygenator appears to be comparable with that of other volatile anaesthetics across PPL membranes. The highfunctioning uptake across PPL membranes has already been shown for enflurane, desflurane, and isoflurane in vivo. 18 -20 In contrast, plasma-tight polymethylpentene (PMP) membranes appear to allow only minimal uptake of isoflurane into blood. 20 Accordingly, existing data show a limited elimination of sevoflurane in PMP oxygenators compared with PPL membrane oxygenators. 21 Our results provide information on the transfer capacity of a PPL oxygenator for sevoflurane over several hours and the SPC during the course of CPB in a routine clinical setting for the first time.
The initial changes in SPC during the course of CPB may be explained by the influence of hypothermia and crystalloid haemodilution due to the priming fluid of the CPB circuit. In our patients, hypothermia and enhancing the oxygenator fresh-gas supply flow increased the SPC, whereas crystalloid haemodilution decreased the SPC. This appears relevant because during CPB, mild to moderate hypothermia is used frequently to decrease oxygen consumption. Furthermore, at the onset of CPB, the priming fluid of the circuit regularly leads to haemodilution and subsequently to a decrease in haematocrit and plasma protein concentrations. In our study group, the initial decrease in SPC after starting CPB was accompanied by a decrease in haematocrit and plasma-albumin concentration (Table 3 ). The haematocrit decreased initially by 30.0%, while SPC decreased parallel by 21.3% (Table 3 ). The haematocrit is an important surrogate parameter that reflects haemodilution and is easily accessible to the anaesthesiologist in the operating theatre. But although haemodilution can be altered by the perfusionist and anaesthesiologist, our data cannot answer the question if avoiding haemodilution will change the course of SPC at the onset of CPB.
The subsequently observed increase in SPC during the following CPB phase was accompanied by a decrease in patient temperature, whereas haemodilution remained unchanged. The increased blood/gas solubility resulted in the observed increase in the SPC until a new level was reached during hypothermia and haemodilution, when the contrasting effects of haemodilution and hypothermia counteracted each other. During the further course of CPB (T7 -TX-1), haemodilution remained nearly unchanged and rewarming of the patients was initiated before weaning from CPB. Thus, sevoflurane blood/gas solubility decreased again because patient temperature increased, resulting in a lower SPC at measurements T9, T10, and TX-1. The patients showed a higher average temperature after weaning from CPB than before CPB (36.78C vs 35.48C, Table 3 ). As a result of this higher body temperature and persistent haemodilution, the SPC did not reach the same level after CPB as before CPB.
The effect of hypothermia and haemodilution on blood solubility during CPB was described for halothane, enflurane, isoflurane, and desflurane in smaller populations or in vitro studies. 11 12 18 19 22 -25 The blood solubility of these volatile anaesthetics was markedly reduced when crystalloids and colloids were used as CPB priming fluids, and the solubilities of anaesthetics increased logarithmically at lower temperatures. 11 12 18 19 22 -25 Zhou and Liu 12 observed that during the course of cardiac surgery, estimated blood/gas partition coefficients of isoflurane were lowest during weaning from CPB, reaching a level of 75% when compared with estimated concentrations before induction of anaesthesia. Our findings confirm these results in terms of sevoflurane because the SPC before weaning from CPB (measurement TX-1) was 71.8% of the SPC during stable application of sevoflurane via the respirator before CPB (measurement T1).
In an in vitro study, the solubility of sevoflurane increased by 5.4%, compared with that at 378C, for each degree reduction in the equilibration temperature. 10 Our in vivo findings confirm the results of these in vitro data for the first time.
In summary, the results show that the pharmacokinetics of sevoflurane during hypothermic CPB are similar to other volatile anaesthetics.
In addition to the already described effects of hypothermia and haemodilution, we found a significant correlation between the oxygenator fresh gas supply flow and the SPC. This finding must be taken into account when high rates of fresh gas flow are used in the oxygenator in special situations during on-pump cardiac surgery, for example, when carbon dioxide insufflation into the pericardial space is used to decrease the prevalence and complications of air embolism after open cardiac procedures. The inflated carbon dioxide then requires high rates of fresh gas flow in the oxygenator to maintain arterial normocapnia. Maintaining a constant concentration of sevoflurane in the oxygenator fresh gas supply in these situations may result in a higher SPC that is independent of blood/gas solubility.
The initial decrease in SPC after initiation of CPB was not accompanied by simultaneous changes in BIS values. And even if the mean BIS values were statistically higher after rewarming to normothermia than during hypothermia, the clinical relevance of these changes might be considered low because no patient showed BIS readings above 55. Most patients showed deep hypnosis with the mean BIS values below 40. These unchanged BIS values in the setting of 20% changes in SPC suggest several possibilities. On the one hand, the demonstrated level of fluctuation in SPC may not be clinically important and high doses of opioids or potentiation by hypothermia affected BIS levels, despite changes in sevoflurane levels. If so, the clinical relevance of the changes in SPC might be considered low and administration of a constant concentration of 1.8 vol% sevoflurane via the oxygenator fresh gas supply results in a sufficient depth of sedation. On the other hand, the BIS may be too insensitive to detect otherwise important changes in SPC. 26 This could be of particular importance because cardiac Sevoflurane plasma concentration during CPB surgery is suspected of being associated with an increased risk of intraoperative awareness. 14 15 27 Measuring the concentration of volatile anaesthetics in the oxygenator gas exhaust port to guide the dosage during CPB has been advocated by several authors. 19 20 23 25 Mets and colleagues found a linear correlation of r 2 ¼0.97
between the desflurane concentration measured at the oxygenator exhaust and concentrations measured from blood gas samples aspirated simultaneously in 10 patients. However, our investigation was unable to confirm these data. The concentration of volatile anaesthetics in the oxygenator exhaust gas depends upon the amount of room-air admixture in the exhaust port flow that enters via the ventilation holes in the bottom of commercially distributed oxygenators. These slots are used by the manufacturer to prevent an undertow on the oxygenator membrane. It must be ensured that the methods adopted for anaesthetic gas scavenging during CPB do not in any way increase or reduce the pressure level at the oxygenator fibres. Therefore, either ventilation holes must be placed in the oxygenator casing by the manufacturer or an open T-piece must be interposed in the oxygenator exhaust, allowing room air to mix with the exhaust gas. It is unclear if this unpredictable amount of room-air admixture contributes to the missing correlation between sevoflurane concentration in the oxygenator exhaust and the SPC, as shown in our results. Our study has some limitations. As the incidence of intraoperative awareness is 0.1 -0.4% in cardiac surgery patients, we cannot expect reliable results on the incidence of awareness in this small study. 15 27 Furthermore, we studied the SPC using only one typical PPL-oxygenator model and cannot exclude that other models may produce different results. Regarding the correlation between oxygenator fresh gas flow and the SPC, it has to be clarified that fresh gas flow was calculated as an independent parameter. A potential bias affecting this correlation may occur when blood flow during CPB influences oxygenator fresh gas flow. The dose of sevoflurane was inspiratory 1.8 vol% before, during, and after CPB, although the dose of volatile anaesthetics is typically guided by measuring the end-tidal alveolar concentration. Because we intended to administer a constant dose of sevoflurane inspiratory via the ventilator and in the oxygenator fresh gas supply, we chose to control the inspiratory sevoflurane concentration. Investigations to evaluate the necessary dose of volatile anaesthetics during CPB to avoid overdosage and to ensure adequate anaesthesia must be performed. In summary, our findings demonstrate a stable transfer capacity of the PPL-oxygenator membrane for sevoflurane over time during on-pump cardiac surgery. Variations in SPC occur and are due to hypothermia, haemodilution, and changes in the fresh gas supply of the oxygenator. For clinical use, measuring the concentration of sevoflurane in the oxygenator exhaust is unreliable for monitoring sevoflurane dosage during CPB. Our results must be taken into account when administering volatile anaesthetics via the PPL membrane oxygenator Compactflo Evolution 
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